Active Surveillance of Candidemia, Australia
Sharon Chen*

, Monica Slavin†, Quoc Nguyen‡, Deborah Marriott‡, E. Geoffrey Playford§, David Ellis¶, Tania C. Sorrell*#, and the Australian Candidemia Study
Author affiliations: *Westmead Hospital, Westmead, New South Wales, Australia; †Royal Melbourne Hospital, Melbourne, Victoria, Australia; ‡St. Vincent's Hospital, Sydney, New South Wales, Australia; §Princess Alexandra Hospital, Brisbane, Queensland, Australia; ¶Women's and Children's Hospital, Adelaide, South Australia, Australia; #University of Sydney, Sydney, New South Wales, Australia
Main Article
Table 4
Multivariate predictors of death by candidemia 30 days after diagnosis, Australia, 2001–2004*
Characteristic |
OR |
95% CI |
p value |
Age >65 y |
3.0 |
2.0–4.3 |
<0.001 |
ICU stay |
3.2 |
2.1–5.0 |
<0.001 |
Corticosteroid therapy |
2.8 |
1.9–4.1 |
<0.001 |
Hemodialysis |
2.4 |
1.4–4.1 |
0.002 |
Hyperalimentation |
1.7 |
1.1–2.5 |
0.006 |
Antimicrobial drug use |
2.1 |
0.9–4.4 |
0.07 |
Neutropenia |
2.2 |
1.3–3.6 |
0.002 |
Sepsis present |
3.1 |
1.7–5.4 |
<0.001 |
Treatment with antifungal agent |
0.01 |
0.06–0.2 |
<0.001 |
Candida glabrata infection |
1.8 |
1.1–2.9 |
0.01 |
Main Article
Page created: November 10, 2011
Page updated: November 10, 2011
Page reviewed: November 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.